FGFR4 AND EZH2 INHIBITORS SYNERGISTICALLY INDUCE HEPATOCELLULAR CARCINOMA APOPTOSIS VIA REPRESSING YAP SIGNALING

FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling

Abstract Background Hepatocellular carcinoma (HCC) is one of the most common and lethal cancers worldwide, but current treatment options remain limited and cause serious life-threatening side effects.Aberrant FGFR4 signaling has been validated as an oncogenic driver of HCC, and EZH2, the In Print catalytic subunit of the PRC2 complex, is a potentia

read more

The Design Concept

Abstract In this volume of Artifact, we wish to explore design through the design concept, and thereby the societal praxis of designers through the theoretical concept of design.Design is praxis, but it is also formed by the way we frame the concept of design.We have endeavoured to give space for a rather broad range of contributors coming from bot

read more